EssilorLuxottica : A pullback can be expected
Entry price | Target | Stop-loss | Potential |
---|
€173.88 |
€165 |
€179.2 |
+5.11% |
---|
Close to the technical resistance level of the current trading range, stocks in EssilorLuxottica should consolidate over the coming trading sessions and move back towards their support based on daily closing prices in the short term.
Summary● According to Refinitiv, the company's ESG score for its industry is good.
Strengths● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Weaknesses● The company benefits from high valuations in earnings multiples.
● With an enterprise value anticipated at 3.34 times the sales for the current fiscal year, the company turns out to be overvalued.
● The valuation of the company is particularly high given the cash flows generated by its activity.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.